← LibraryThe Cartilage Guide

Animal · 2011

Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions

Ilic S, Drmic D, Franjic S, Seiwerth S, Sikiric P, et al. · Life Sciences

Preclinicalcounts toward this tier

Diclofenac alone produced gastric, intestinal and liver lesions, raised bilirubin, AST and ALT, enlarged the liver and caused hepatic encephalopathy with cortical and cerebellar oedema and damaged neurons; both BPC 157 routes antagonised the whole cluster.

Population
Rats given diclofenac 12.5 mg/kg i.p. daily for three days
Intervention
BPC 157 10 µg/kg or 10 ng/kg i.p., or per-orally in drinking water (0.16 µg/mL or 0.16 ng/mL)
Comparator
Diclofenac alone
Limitations
Originating network; a supratherapeutic NSAID dose, so it models toxicity rather than the routine analgesic use a reader would have in mind.

Cited by

1 entry references this study

  • BPC-157

    PeptidesPreclinical & experimental

    PRECL.